Sight Sciences Beat Consensus Estimates

Sight Sciences (SGHT) reported a loss of $0.08 per share on revenue of $23.39 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.15 per share on revenue of $21.75 million. The company beat consensus estimates by 46.67% while revenue grew 19.55% on a year-over-year basis.

Sight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients’ lives.